Literature DB >> 10070916

Natural logarithmic estimates of Kt/V in the pediatric hemodialysis population.

S L Goldstein1, J M Sorof, E D Brewer.   

Abstract

The natural logarithm formula for Kt/V proposed by Daugirdas is recognized as a valid and simple alternative to formal urea kinetic modeling (UKM) in adults receiving hemodialysis. No data have been published to validate the use of this formula in infants, children, and adolescents. We compared Kt/V derived by formal UKM with the natural logarithmic formula for 103 treatments in 21 pediatric end-stage renal disease patients receiving chronic hemodialysis. Values for Kt/V derived by formal UKM ranged from 0.65 to 2.06. Patients ranged in age from 1.8 to 22.5 years and in dry weight from 10.2 to 82.5 kg. The largest percent error between the two methods for any data point was less than 6%. The total error (absolute value percent error + 2 SD) was less than 6% across the entire range of dry weights. Our data show excellent agreement between formal UKM and the natural logarithm formula for Kt/V in pediatric hemodialysis patients, even those weighing less than 30 kg. These results support the use of the natural logarithm formula as a valid alternative to formal UKM in children. The simplicity of this formula should allow for the use of Kt/V as the best measure to study the relationship between delivered dialysis dose and outcomes in children.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10070916     DOI: 10.1016/s0272-6386(99)70189-7

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  12 in total

Review 1.  Hemodialysis in children: general practical guidelines.

Authors:  M Fischbach; A Edefonti; C Schröder; A Watson
Journal:  Pediatr Nephrol       Date:  2005-06-10       Impact factor: 3.714

2.  Patterns of use of vascular catheters for hemodialysis in children in the United States.

Authors:  Jeffrey J Fadrowski; Wenke Hwang; Alicia M Neu; Barbara A Fivush; Susan L Furth
Journal:  Am J Kidney Dis       Date:  2008-10-31       Impact factor: 8.860

3.  Two-point normalized protein catabolic rate overestimates nPCR in pediatric hemodialysis patients.

Authors:  Poyyapakkam R Srivaths; Scott Sutherland; Steven Alexander; Stuart L Goldstein
Journal:  Pediatr Nephrol       Date:  2012-12-02       Impact factor: 3.714

Review 4.  Dialysis disequilibrium syndrome.

Authors:  Diana Zepeda-Orozco; Raymond Quigley
Journal:  Pediatr Nephrol       Date:  2012-06-19       Impact factor: 3.714

5.  Comparison of single-pool and equilibrated Kt/V values for pediatric hemodialysis prescription management: analysis from the Centers for Medicare & Medicaid Services Clinical Performance Measures Project.

Authors:  Stuart L Goldstein; Andrew Brem; Bradley A Warady; Barbara Fivush; Diane Frankenfield
Journal:  Pediatr Nephrol       Date:  2006-05-17       Impact factor: 3.714

6.  Short, frequent, 5-days-per-week, in-center hemodialysis versus 3-days-per week treatment: a randomized crossover pilot trial through the Midwest Pediatric Nephrology Consortium.

Authors:  Benjamin L Laskin; Guixia Huang; Eileen King; Denis F Geary; Christoph Licht; Joshua P Metlay; Susan L Furth; Tom Kimball; Mark Mitsnefes
Journal:  Pediatr Nephrol       Date:  2017-04-08       Impact factor: 3.714

Review 7.  Hemodialysis in children with end-stage renal disease.

Authors:  Dominik Müller; Stuart L Goldstein
Journal:  Nat Rev Nephrol       Date:  2011-09-06       Impact factor: 28.314

8.  Cinacalcet is efficacious in pediatric dialysis patients.

Authors:  Douglas M Silverstein; Kanwal K Kher; Asha Moudgil; Mona Khurana; Jennifer Wilcox; Kathleen Moylan
Journal:  Pediatr Nephrol       Date:  2008-02-21       Impact factor: 3.714

9.  Adequacy of dialysis in children: does small solute clearance really matter?

Authors:  Stuart L Goldstein
Journal:  Pediatr Nephrol       Date:  2003-11-22       Impact factor: 3.714

10.  Clinical experience with darbepoietin alfa (NESP) in children undergoing hemodialysis.

Authors:  Tommaso De Palo; Mario Giordano; Fabrizio Palumbo; Rosa Bellantuono; Giovanni Messina; Vincenzo Colella; Angela D Caringella
Journal:  Pediatr Nephrol       Date:  2004-01-27       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.